Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2703456 | 0.76 | LMNA (0.33) | CA2MAPK1LMNACYP2C9HSD17B10 | |
| SCHEMBL1707381 | 0.75 | LMNA (0.36) | LMNATSHRALDH1A1FFAR3TP53 | |
| SCHEMBL10794078 | 0.75 | DGAT1 (0.35) | CA2MAPK1CYP2C9 | |
| SCHEMBL8689396 | 0.74 | TSHR (0.38) | CA2MAPK1CYP2C9HSD17B10TSHR | |
| SCHEMBL1707223 | 0.73 | LMNA (0.35) | LMNA | |
| SCHEMBL1158338 | 0.73 | — | — | |
| SCHEMBL1572815 | 0.72 | TSHR (0.36) | CA2MAPK1CYP2C9HSD17B10TSHR | |
| SCHEMBL3646440 | 0.72 | TSHR (0.50) | CA2MAPK1CYP2C9HSD17B10TSHR | |
| SCHEMBL5369984 | 0.72 | TSHR (0.36) | CA2MAPK1CYP2C9HSD17B10TSHR | |
| SCHEMBL3391927 | 0.72 | SLC1A2 (0.38) | CA2MAPK1CYP2C9HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504436-A | Improved preparation method of gemfibrozil intermediate | 山东精进药业有限公司 | 2025-02-25 | — | — | CN | disclosed |